XML 10 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 33,226 $ 19,453 $ 92,218 $ 60,268
General and administrative 4,395 3,889 13,272 14,277
Total operating expenses 37,621 23,342 105,490 74,545
Loss from operations (37,621) (23,342) (105,490) (74,545)
Other income:        
Interest income 2,928 1,919 9,388 4,774
Other income (expense) 138 (79) 195 (112)
Total other income 3,066 1,840 9,583 4,662
Net loss $ (34,555) $ (21,502) $ (95,907) $ (69,883)
Net loss per share, basic (in dollars per share) $ (0.6) $ (0.48) $ (1.8) $ (1.66)
Net loss per share, diluted (in dollars per share) $ (0.6) $ (0.48) $ (1.8) $ (1.66)
Weighted average shares used to compute net loss per share, basic (in shares) 57,262,803 44,977,161 53,194,081 41,999,978
Weighted average shares used to compute net loss per share, diluted (in shares) 57,262,803 44,977,161 53,194,081 41,999,978